Five Key Technologies for Promoting the Green Transformation of Pharmaceutical Production Processes

Amid the global transition toward green pharmaceutical manufacturing, traditional batch processes face critical challenges, including high solvent consumption, reliance on precious-metal catalysts, excessive waste generation, inefficient chiral synthesis, and safety and energy constraints. This review examines five enabling technologies that are driving this transformation: (1) green analytical methods coupled with artificial intelligence (AI) reduce solvent use and waste while enabling data-driven method development; (2) green catalysis, comprising nonprecious-metal catalysis and biocatalysis, offers a sustainable alternative to platinum-group metals, lowering both cost and environmental impact; (3) chiral synthesis based on crystallization-induced asymmetric transformation overcomes the 50% theoretical yield ceiling of classical resolution, enabling highly efficient enantioselective synthesis; (4) continuous flow manufacturing enhances process safety and efficiency through the integration of unit operations; and (5) photocatalysis harnesses light as a clean energy source and, in combination with AI-enabled closed-loop control and online monitoring, allows precise regulation of reaction conditions and expands the accessible chemical space. Collectively, these five technologies steer the industry toward lower energy consumption, reduced emissions, and greater process intelligence. However, challenges remain, and future priorities may include smarter process mass intensity metrics, multitechnology integration, unified green evaluation standards, intensified unit operations, and intelligent scale-up strategies for sustainable pharmaceutical production. By clarifying how these technologies interrelate, this review offers a framework that can help researchers and practitioners prioritize green process development and accelerate the industrial adoption of sustainable pharmaceutical manufacturing.

Authors

Publication Details

Journal
Pharmaceutical Fronts
Published
2026-11-20
DOI
https://doi.org/10.1055/a-2979-9406
Primary Topic
Chemistry and Chemical Engineering
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Five Key Technologies for Promoting the Green Transformation of Pharmaceutical Production Processes

瞿军, Yunxiang Qiao, Yun Qian, Dehua Gao et al.
4 links
Pharmaceutical Fronts
Chemistry and Chemical Engineering
article

Five Key Technologies for Promoting the Green Transformation of Pharmaceutical Production Processes

瞿军, Yunxiang Qiao, Yun Qian, Dehua Gao, Fan Yang, Haitang Hua
article en

Abstract

Amid the global transition toward green pharmaceutical manufacturing, traditional batch processes face critical challenges, including high solvent consumption, reliance on precious-metal catalysts, excessive waste generation, inefficient chiral synthesis, and safety and energy constraints. This review examines five enabling technologies that are driving this transformation: (1) green analytical methods coupled with artificial intelligence (AI) reduce solvent use and waste while enabling data-driven method development; (2) green catalysis, comprising nonprecious-metal catalysis and biocatalysis, offers a sustainable alternative to platinum-group metals, lowering both cost and environmental impact; (3) chiral synthesis based on crystallization-induced asymmetric transformation overcomes the 50% theoretical yield ceiling of classical resolution, enabling highly efficient enantioselective synthesis; (4) continuous flow manufacturing enhances process safety and efficiency through the integration of unit operations; and (5) photocatalysis harnesses light as a clean energy source and, in combination with AI-enabled closed-loop control and online monitoring, allows precise regulation of reaction conditions and expands the accessible chemical space. Collectively, these five technologies steer the industry toward lower energy consumption, reduced emissions, and greater process intelligence. However, challenges remain, and future priorities may include smarter process mass intensity metrics, multitechnology integration, unified green evaluation standards, intensified unit operations, and intelligent scale-up strategies for sustainable pharmaceutical production. By clarifying how these technologies interrelate, this review offers a framework that can help researchers and practitioners prioritize green process development and accelerate the industrial adoption of sustainable pharmaceutical manufacturing.

Pharmaceutical Fronts
Responsible consumption and production, Industry, innovation and infrastructure
Chemistry and Chemical Engineering
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Five Key Technologies for Promoting the Green Transformation of Pharmaceutical Production Processes — 瞿军, Yunxiang Qiao, et al. · Pharmaceutical Fronts (2026) | TGRS Research Map | TGRS